CICERI, PAOLA
CICERI, PAOLA
Dipartimento di Scienze della Salute
How are developments in the treatment armamentarium of hyperphosphatemia addressing the current therapeutic challenges?
2026 L. Magagnoli, P. Ciceri, M. Cozzolino
High glucose enhances inflammation-driven platelet adhesion to endothelial cells in vitro
2026 M. Scavone, A. Fioretti, M. Molinaro, C. Ghali, C. Martinelli, T. Mencarini, S. Bozzi, N. Santo, U. Gianelli, M. Miozzo, M. Guazzi, G.M. Podda, M. Cozzolino, P. Ciceri
Vascular Calcification in Advanced Chronic Kidney Disease: Epidemiology, Pathophysiology, and Treatment
2026 R. Fernando Rivera, M. Teresa Sciarrone Alibrandi, N. Edvige Foligno, L. Magagnoli, P. Ciceri, M. Cozzolino
Uremic Toxin‐Driven Vascular Calcification in Chronic Kidney Disease: Molecular Pathways and Integrated Phenotypes
2026 R. Fernando Rivera, M. Teresa Sciarrone Alibrandi, N. Edvige Foligno, L. Magagnoli, P. Ciceri, M. Cozzolino
Apoptotic Bodies in Kidney Disease: Orchestrators of Inflammation, Fibrosis, and Repair
2026 M. Cozzolino, P. Ciceri
RAASi, MRA and FGF-23 in CKD progression: the usual suspects?
2025 G. Cianciolo, M. Provenzano, L. Hu, S. Barbuto, M.J. Soler, P. Ciceri, M. Cozzolino, G. La Manna
Calcimimetics and vascular calcification
2025 A. Chandu, C. Arana, J. Daniel Díaz-García, M. Cozzolino, P. Ciceri, J. Torregrosa
MCO Membranes and FGF-23: Advancing Dialysis Strategies for Better Outcomes?
2025 S. Barbuto, L. Magagnoli, G. Cianciolo, G. La Manna, M. Cozzolino, P. Ciceri
Critical evaluation of therapeutic targeting in chronic kidney disease: where do we stand 5 years on?
2025 M. Cozzolino, L. Magagnoli, P. Ciceri
From Physicochemical Classification to Multidimensional Insights: A Comprehensive Review of Uremic Toxin Research
2025 M. Cozzolino, L. Magagnoli, P. Ciceri
Vitamin D: are all compounds equal?
2025 L. Magagnoli, M. Cassia, A. Galassi, P. Ciceri, E. Massò, R. Gelpi, J. Bover, M. Cozzolino
Kynurenine Promotes Phosphate-Induced Endothelial Calcification via Endothelial-to-Mesenchymal Transition, Osteoblastic Differentiation and AhR Activation
2025 M. Molinaro, M. Cozzolino, P. Ciceri
High-phosphate Causes Endothelial Extracellular Matrix Calcification by Inducing Endothelial Cell Mesenchymal Transition and Osteoblastic Differentiation
2025 P. Ciceri, L. Artioli, M. Molinaro, M. Falleni, D. Tosi, C. Martinelli, N. Santo, O. Rondinone, M. Miozzo, P. Bianchi, U. Gianelli, L. Fontana, M. Cozzolino
Klotho: a potential therapeutic target in aging and neurodegeneration beyond chronic kidney disease—a comprehensive review from the ERA CKD-MBD working group
2024 M. Kanbay, S. Copur, L. Ozbek, A. Mutlu, D. Cejka, P. Ciceri, M. Cozzolino, M.L. Haarhaus
Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, Current treatments and investigational drugs
2024 L. Magagnoli, P. Ciceri, M. Cozzolino
Angiopoietin as A Novel Prognostic Marker in Kidney Disease
2024 A.B. Yildiz, S. Copur, C. Tanriover, F. Yavuz, S. Vehbi, A. Gaipov, L. Magagnoli, P. Ciceri, M. Cozzolino, M. Kanbay
Iron biology
2024 L. Del Vecchio, D. Girelli, F. Vinchi, M. Cozzolino, S. Elliott, P. B Mark, L. Valenti, C. Qian, Q. Guo, Z. Qian, P. Ciceri, F. Locatelli
Patient-specific multifactorial mortality risk assessment using classification and regression tree analysis in the context of ambulatory blood pressure monitoring
2024 B.T. Çetin, N.B. Hasbal, E. Cevik, O.E. Sahin, M. Akyol, Z. Kalay, D. Ucku, C. Tanriover, M. Güldan, L. Özbek, O. Memetoglu, M.E. Erden, S. Copur, I. Siriopol, D. Siriopol, P. Ciceri, M. Cozzolino, M. Kanbay
Levels of Cell-Free DNA in Kidney Failure Patients before and after Renal Transplantation
2023 C. Leotta, L. Hernandez, L. Tothova, S. Arefin, P. Ciceri, M.G. Cozzolino, P. Barany, M. Chromek, P. Stenvinkel, K. Kublickiene
Choice of the Dialysis Modality: Practical Considerations
2023 M. Torreggiani, G.B. Piccoli, M.R. Moio, F. Conte, L. Magagnoli, P. Ciceri, M. Cozzolino